Controversies in Fibrosis and Emphysema
Antoniou, Katerina M; Bibaki, Eleni; Margaritopoulos, George A.
Arch. bronconeumol. (Ed. impr.)
; 53(5): 231-232, mayo 2017.
Artículo en Inglés | IBECS (España) | ID: ibc-162356
Documentos relacionados
Association between the use of statins and risk of interstitial lung disease/idiopathic pulmonary fibrosis: time-dependent analysis of population-based nationwide data.
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry.
Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis.
Identification of Idiopathic Pulmonary Fibrosis and Prediction of Disease Severity via Machine Learning Analysis of Comprehensive Metabolic Panel and Complete Blood Count Data.
Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes.
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Short Telomere Syndrome presenting with pulmonary fibrosis, liver cirrhosis and hepatopulmonary syndrome: a case report.
Sleep-related breathing disorders in idiopathic pulmonary fibrosis are frequent and may be associated with pulmonary vascular involvement.
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.